-
Je něco špatně v tomto záznamu ?
G-quadruplex, Friend or Foe: The Role of the G-quartet in Anticancer Strategies
J. Carvalho, JL. Mergny, GF. Salgado, JA. Queiroz, C. Cruz
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- aptamery nukleotidové farmakologie terapeutické užití MeSH
- G-kvadruplexy účinky léků MeSH
- lidé MeSH
- ligandy MeSH
- nádory farmakoterapie MeSH
- nukleové kyseliny farmakologie MeSH
- oligodeoxyribonukleotidy farmakologie terapeutické užití MeSH
- protinádorové látky farmakologie terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The clinical applicability of G-quadruplexes (G4s) as anticancer drugs is currently being evaluated. Several G4 ligands and aptamers are undergoing clinical trials following the notable examples of quarfloxin and AS1411, respectively. In this review, we summarize the latest achievements and breakthroughs in the use of G4 nucleic acids as both therapeutic tools ('friends', as healing anticancer drugs) and targets ('foes', within the harmful cancer cell), particularly using aptamers and quadruplex-targeted ligands, respectively. We explore the recent research on synthetic G4 ligands toward the discovery of anticancer therapeutics and their mechanism of action. Additionally, we highlight recent advances in chemical and structural biology that enable the design of specific G4 aptamers to be used as novel anticancer agents.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026607
- 003
- CZ-PrNML
- 005
- 20211026132751.0
- 007
- ta
- 008
- 211013s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.molmed.2020.05.002 $2 doi
- 035 __
- $a (PubMed)32467069
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Carvalho, Josué $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
- 245 10
- $a G-quadruplex, Friend or Foe: The Role of the G-quartet in Anticancer Strategies / $c J. Carvalho, JL. Mergny, GF. Salgado, JA. Queiroz, C. Cruz
- 520 9_
- $a The clinical applicability of G-quadruplexes (G4s) as anticancer drugs is currently being evaluated. Several G4 ligands and aptamers are undergoing clinical trials following the notable examples of quarfloxin and AS1411, respectively. In this review, we summarize the latest achievements and breakthroughs in the use of G4 nucleic acids as both therapeutic tools ('friends', as healing anticancer drugs) and targets ('foes', within the harmful cancer cell), particularly using aptamers and quadruplex-targeted ligands, respectively. We explore the recent research on synthetic G4 ligands toward the discovery of anticancer therapeutics and their mechanism of action. Additionally, we highlight recent advances in chemical and structural biology that enable the design of specific G4 aptamers to be used as novel anticancer agents.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x farmakologie $x terapeutické užití $7 D000970
- 650 _2
- $a aptamery nukleotidové $x farmakologie $x terapeutické užití $7 D052157
- 650 _2
- $a G-kvadruplexy $x účinky léků $7 D054856
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a nádory $x farmakoterapie $7 D009369
- 650 _2
- $a nukleové kyseliny $x farmakologie $7 D009696
- 650 _2
- $a oligodeoxyribonukleotidy $x farmakologie $x terapeutické užití $7 D009838
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Mergny, Jean-Louis $u University of Bordeaux, ARNA Laboratory, INSERM, U1212, CNRS UMR 5320, IECB, F-33600 Pessac, France; Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, Brno, 612 65, Czech Republic
- 700 1_
- $a Salgado, Gilmar F $u University of Bordeaux, ARNA Laboratory, INSERM, U1212, CNRS UMR 5320, IECB, F-33600 Pessac, France
- 700 1_
- $a Queiroz, João A $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
- 700 1_
- $a Cruz, Carla $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal. Electronic address: carlacruz@fcsaude.ubi.pt
- 773 0_
- $w MED00006668 $t Trends in molecular medicine $x 1471-499X $g Roč. 26, č. 9 (2020), s. 848-861
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32467069 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132758 $b ABA008
- 999 __
- $a ok $b bmc $g 1715363 $s 1147114
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 26 $c 9 $d 848-861 $e 20200525 $i 1471-499X $m Trends in molecular medicine $n Trends Mol Med $x MED00006668
- LZP __
- $a Pubmed-20211013
